Alloy Therapeutics

Summary active Updated Apr 16, 2026

This profile is AI-generated. If you spot an error, please help us fix it by sharing a URL to the correct information.

Location Boston, MA
Founded 2017
Latest Stage Series E
Total Raised $40M+
Sector
biotech AI drug-discovery

Investors

8VC series-e (2026)
Founders Fund series-e (2026)

Founders

Errik Anderson Founder & CEO

About

Alloy Therapeutics is a Boston-based tech-enabled biotech infrastructure company that has collaborated with more than 200 partners across antibodies, bispecifics, genetic medicines, and cell therapies 1. The company has over 100 licensed therapeutic programs, including 22 in clinical development 1. The Series E valued Alloy at $1 billion 1.

Funding History

Date Round Amount Lead Co-investors
2026-04-15 Series E $40M 8VC, JIC Venture Growth Investments, Echo Capital (co-leads) Mubadala Capital, Presight Capital, Thiel Capital, Founders Fund, Alexandria Venture Investments, Gaingels, Ulysses Diversified Holdings 123

What Investors Say

No verified investor quotes available at this time.

What Founders Say

No verified founder quotes available at this time.

Sources

  1. BioSpace, “Alloy Therapeutics Announces $40M Series E to Scale Tech-Enabled Biotech Infrastructure,” April 15, 2026. https://www.biospace.com/press-releases/alloy-therapeutics-announces-40m-series-e-to-scale-tech-enabled-biotech-infrastructure↩↩↩↩

  2. BusinessWire, “Alloy Therapeutics Announces $40M Series E to Scale Tech-Enabled Biotech Infrastructure,” April 15, 2026, accessed May 2026. https://www.businesswire.com/news/home/20260415032940/en/Alloy-Therapeutics-Announces-$40M-Series-E-to-Scale-Tech-Enabled-Biotech-Infrastructure — Primary press-wire source confirming April 15, 2026 announcement of $40M Series E at $1B valuation, co-led by 8VC, JIC Venture Growth Investments, and Echo Capital. ↩

  3. PharmiWeb, “Alloy Therapeutics Announces $40M Series E to Scale Tech-Enabled Biotech Infrastructure,” April 15, 2026, accessed May 2026. https://www.pharmiweb.com/press-release/2026-04-15/alloy-therapeutics-announces-40m-series-e-to-scale-tech-enabled-biotech-infrastructure — Independent confirmation of April 15, 2026 Series E announcement; describes use of proceeds for AI/ML data layer and clinical development services. ↩